Autopsy report · NCT01415947

V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse

“Company business decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 2 years 4 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Edwards Lifesciences

Sponsor type

Industry

Conditions

Mitral Leaflet Prolapse

Interventions

V Chordal

Participants

5

Sites

1

Countries

Italy

Trials that died the same way

• Non-invasive Neurostimulation for the Relief of Migraine
  “Company decision” (92% match in meaning)
• 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
  “Company's decision” (89% match in meaning)
• Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System
  “Business Decision” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.